

NUMBER_CALL_API_BPM = 4 

BPM_QUESTIONS_1 = [  
    {  
        "question": "Identify and summarize the valuation process described in the Policy, specifying all the phases adopted and in particular the actors involved (such as the CFO, CEO, COO, investment team, audit team, risk management team, valuation team, external advisor).",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 1",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "List the main methodologies for determining the value of instruments indicated in the Policy, and specify whether a hierarchy among them is defined.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "When the Policy refers to the Discounted Cash Flow (DCF) methodology, specify whether the Asset Side (FCFF) or the Equity Side (FCFE) approach is used.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Discounted Cash Flow (Equity)",  
        "level4": "Process 1"  
    },  
    {  
        "question": "Describe how the Policy estimates the Cost of Equity, explicitly indicating which inputs are used in the calculation.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Discounted Cash Flow (Equity)",  
        "level4": "Process 2"  
    },  
    {  
        "question": "Extract from the Policy the criteria used to identify the risk-free rate and the related source.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Discounted Cash Flow (Equity)",  
        "level4": "Process 3"  
    },  
    {  
        "question": "Specify how the Policy identifies premiums (such as market and equity premiums) and indicate their sources.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Discounted Cash Flow (Equity)",  
        "level4": "Process 4"  
    },  
    {  
        "question": "Identify the procedures described in the Policy for determining the beta coefficient used, and indicate its source.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Discounted Cash Flow (Equity)",  
        "level4": "Process 5"  
    },  
    {  
        "question": "When Terminal Value (TV) is estimated using the Discounted Cash Flow (DCF) methodology, verify if the Gordon model is applied and describe how the reference growth rate is determined.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Discounted Cash Flow (Equity)",  
        "level4": "Process 6"  
    }  
] 

BPM_QUESTIONS_2 = [  
    {  
        "question": "If the Policy adopts the multiples methodology, explicitly state whether discounts are applied and describe the criteria by which they are determined.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Multiples (Equity)",  
        "level4": "Process 1"  
    },  
    {  
        "question": "Identify whether the manager uses market multiples, transaction multiples, or a combination of both to assign value to the investee, and specify the circumstances for each.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Multiples (Equity)",  
        "level4": "Process 2"  
    },  
    {  
        "question": "If transaction multiples are used, list the criteria adopted by the manager to identify the comparable multiple.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Multiples (Equity)",  
        "level4": "Process 3"  
    },  
    {  
        "question": "Check whether, when using transaction multiples, the Policy provides for the application of an additional illiquidity discount at the level of multiple/Enterprise Value/Equity Value.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Multiples (Equity)",  
        "level4": "Process 4"  
    },  
    {  
        "question": "If market multiples are used, state the criteria adopted by the manager to identify the comparable multiple.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Multiples (Equity)",  
        "level4": "Process 5"  
    },  
    {  
        "question": "Verify if the Policy still provides for the application of an illiquidity discount at the level of multiple/Enterprise Value/Equity Value when market multiples are used.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Multiples (Equity)",  
        "level4": "Process 6"  
    },  
    {  
        "question": "If the Terminal Value is estimated using a multiples methodology, specify how the reference multiple is determined according to the Policy.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Multiples (Equity)",  
        "level4": "Process 7"  
    }  
]  


BPM_QUESTIONS_3 = [  
    {  
        "question": "Identify whether the Policy clearly states which inputs are used to build future cash flows (e.g., invested amount, fixed/variable rate, drawdown and repayment schedules, etc.).",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Mark to Model (Debt)",  
        "level4": "Process 1"  
    },  
    {  
        "question": "Describe the process through which the discount rate is determined according to the Policy. Specify whether a single rate or a curve is used.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Mark to Model (Debt)",  
        "level4": "Process 2"  
    },  
    {  
        "question": "Explain how the spread is determined in the Policy. Indicate if it is extrapolated from a basket of comparable securities or if it is the result of an internal model.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Mark to Model (Debt)",  
        "level4": "Process 3"  
    },  
    {  
        "question": "Verify whether the Policy provides a process for manual model adjustment in case of exceptional or special events. State whether the manager documents and justifies any such adjustments or provisions.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Mark to Model (Debt)",  
        "level4": "Process 4"  
    },  
    {  
        "question": "Determine if the Policy takes into consideration any guarantees when valuing instruments.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Mark to Model (Debt)",  
        "level4": "Process 5"  
    },  
    {  
        "question": "If the manager adopts valuation methodologies different from those previously described (such as Option-based Valuation, Stochastic Methods, Weighted Probabilistic Methods, Recovery Approach, NPL valuation), provide a complete description of the process adopted.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 2",  
        "level3": "Other",  
        "level4": ""  
    },  
    {  
        "question": "Describe whether the Policy provides guidance on the inputs used, distinguishing between observable inputs (such as economic, balance sheet, and financial variables required for the valuation) and the valuation assumptions underlying the models.",  
        "level1": "Valuation Policy",  
        "level2": "Hypothesis 3",  
        "level3": "",  
        "level4": ""  
    }  
]

BPM_QUESTIONS_4 = [  
    {  
        "question": "Check if the documentation includes the fundamental characteristics of target companies or projects. Summarize these key characteristics if present.",  
        "level1": "Quarterly Documentation",  
        "level2": "Hypothesis 1",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "For each asset within the fund, determine whether sufficient quantitative metrics are provided to assess its economic/financial performance. List the provided metrics if available.",  
        "level1": "Quarterly Documentation",  
        "level2": "Hypothesis 2",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Verify whether the format and content of the reporting follow standards consistent with market best practices. Describe these standards if identified.",  
        "level1": "Quarterly Documentation",  
        "level2": "Hypothesis 3",  
        "level3": "",  
        "level4": ""  
    }  
]  

BPM_QUESTIONS_LIST= [BPM_QUESTIONS_1 ,BPM_QUESTIONS_2 ,BPM_QUESTIONS_3 ,BPM_QUESTIONS_4]


ITA_BPM_QUESTIONS_ITA = [
{"question":"La Policy descrive puntualmente il processo valutativo, specificando le fasi e i criteri adottati?", "level1":"Policy di Valutazione", "level2":"Ipotesi 1", "level3":"", "level4":""},

{"question":"La Policy individua chiaramente le principali metodologie per la determinazione degli strumenti? In caso di utilizzo di pi√π metodologie, definirne la gerarchia.", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"", "level4":""},

{"question":"Il gestore nell'utilizzo del DCF come metodologia di valorizzazione definisce se l'approccio risulta essere Asset Side (FCFF) o Equity Side (FCFE)?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Discounted Cash Flow (Equity)", "level4":"Processo 1"},

{"question":"Nella stima del Cost of Equity, il gestore definisce puntualmente quali sono gli input impiegati nel calcolo?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Discounted Cash Flow (Equity)", "level4":"Processo 2"},

{"question":"Come viene individuato il risk free rate? Qual √® la fonte?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Discounted Cash Flow (Equity)", "level4":"Processo 3"},

{"question":"Come vengono individuati i premi (market, equity)? Quali sono le fonti?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Discounted Cash Flow (Equity)", "level4":"Processo 4"},

{"question":"Come viene individuato il beta adottato? Qual √® la fonte?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Discounted Cash Flow (Equity)", "level4":"Processo 5"},

{"question":"Se il Terminal Value venisse individuato tramite DCF, verrebbe applicato il modello di gordon? Come viene individuato il growth rate di riferimento?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Discounted Cash Flow (Equity)", "level4":"Processo 6"},

{"question":"Nel caso di metodologia a multipli, sono utilizzati sconti? Come vengono determinati?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Multipli (Equity)", "level4":"Processo 1"},

{"question":"Il gestore utilizza multipli di mercato, multipli da transazione o una combinazione degli stessi nell'attribuzione del valore della partecipata?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Multipli (Equity)", "level4":"Processo 2"},

{"question":"In caso di multipli transattivi, che criteri adotta il gestore nell'individuazione del multiplo comparabile?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Multipli (Equity)", "level4":"Processo 3"},

{"question":"In caso di multipli transattivi, il gestore impiega comunque uno sconto di illiquidit√† a livello di multiplo/Enterprise Value/Equity Value?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Multipli (Equity)", "level4":"Processo 4"},

{"question":"In caso di multipli di mercato, che criteri adotta il gestore nell'individuazione del multiplo comparabile?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Multipli (Equity)", "level4":"Processo 5"},

{"question":"In caso di multipli di mercato, il gestore impiega comunque uno sconto di illiquidit√† a livello di multiplo/Enterprise Value/Equity Value?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Multipli (Equity)", "level4":"Processo 6"},

{"question":"Se il Terminal Value venisse stimato tramite multiplo, come viene determinato il multiplo in oggetto?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Multipli (Equity)", "level4":"Processo 7"},

{"question":"Vengono esplicitati chiaramente gli input utilizzati per la costruzione dei flussi di cassa futuri (ammontare investito, tasso fisso/variabile, previsioni di drawdown e rimborsi, etc.)?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Mark to Model (Debito)", "level4":"Processo 1"},

{"question":"Come viene determinato il tasso di sconto? √à un tasso unico per tutti i flussi di cassa o una curva? √à costruita partendo da curva RFR e somma di eventuali addizionali spread? Se si quali?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Mark to Model (Debito)", "level4":"Processo 2"},

{"question":"Come viene determinato lo spread? Viene estrapolato da paniere di comparable? √à frutto di modello interno?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Mark to Model (Debito)", "level4":"Processo 3"},

{"question":"In presenza di eventi eccezionali o special events, √® previsto un processo di aggiustamento manuale del modello? Il gestore fornisce una razionale documentato e trasparente a supporto di eventuali rettifiche o provisioning?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Mark to Model (Debito)", "level4":"Processo 4"},

{"question":"La presenza di eventuali garanzie, sono tenute in considerazione?", "level1":"Policy di Valutazione", "level2":"Ipotesi 2", "level3":"Mark to Model (Debito)", "level4":"Processo 5"},

{"question":"La Policy fornisce indicazioni sugli input utilizzati, distinguendo tra input osservabili (le grandezze economico-patrimoniali-finanziarie necessarie per la valutazione) e le ipotesi valutative sottostanti i modelli?", "level1":"Policy di Valutazione", "level2":"Ipotesi 3", "level3":"", "level4":""},

{"question":"La documentazione include le caratteristiche fondamentali delle societ√† o dei progetti target?", "level1":"Documentazione Trimestrale", "level2":"Ipotesi 1", "level3":"", "level4":""},

{"question":"Per ogni asset interno al fondo, sono fornite sufficienti metriche quantitative che permettono di stabilirne l'andamento economico/finanziario?", "level1":"Documentazione Trimestrale", "level2":"Ipotesi 2", "level3":"", "level4":""},

{"question":"Il formato e il contenuto della reportistica seguono standard coerenti con le best practice di mercato?", "level1":"Documentazione Trimestrale", "level2":"Ipotesi 3", "level3":"", "level4":""}
]



#########################################################################################################################################################
########################################################################################################################################################
########################################################################################################################################################
#####

###################################################################################################################################################





########################################################################################################################################################
########################################################################################################################################################
########################################################################################################################################################
########################################################################################################################################################

NUMBER_API_CALL_IN6 = 8
ARA_PRIVATE_EQUITY_0= [{"question": "What is the percentage of turnover in the country with the highest exposure, and how does geographical concentration impact the company's revenues?", "level1": "Counterparty Risk", "level2": "Geographical concentration", "level3": "", "level4": ""},
                            {"question": "What is the percentage of turnover for the primary product or business line, and how does revenue distribution affect concentration risk? ", "level1": "Counterparty Risk", "level2": "Concentration per product/business line", "level3": "", "level4": ""},
                              {"question": "What percentage of turnover is generated by the top three customers, and how does customer concentration impact the business risk? Refer also to distribution channel diversification and the adopted distribution model (B2B, B2C, \u2026) ", "level1": "Counterparty Risk", "level2": "Customer concentration", "level3": "", "level4": ""}, 
                              {"question": "What percentage of total procurement costs is attributed to the top three suppliers, and how does supplier concentration impact business risk? ", "level1": "Counterparty Risk", "level2": "Suppliers concentration", "level3": "", "level4": ""},
                                {"question": "Which is the size of the company, that is the last revenue available? \n                        -Revenue > 150 mln is low risk; \n                        -50 mln < Revenue \u2264 150 mln is medium-low risk;\n                        -20 mln < Revenue \u2264 50 mln is medium risk; \n                        -7,5 mln < Revenue \u2264 20 mln is medium-high risk \n                        -Revenue  \u2264 7,5 mln is high risk ", "level1": "Counterparty Risk", "level2": "Target size", "level3": "", "level4": ""}]
ARA_PRIVATE_EQUITY_1= [{"question": "What is the lock-up period for the shareholders?", "level1": "Liquidity Risk", "level2": "Shareholders' Agreements", "level3": "", "level4": ""},
                           {"question":"What are the Tag Along and Drag Along clauses after the lock-up period?", "level1": "Liquidity Risk", "level2": "Shareholders' Agreements", "level3": "", "level4": ""},
                           {"question": "Are there any Call or Put options?", "level1": "Liquidity Risk", "level2": "Shareholders' Agreements", "level3": "", "level4": ""},
                             {"question": "Is there a mandate to sell? If so, what are the conditions?", "level1": "Liquidity Risk", "level2": "Shareholders' Agreements", "level3": "", "level4": ""},
                               {"question": "Are there any rights of refusal? If so, who holds the pre-emption rights?", "level1": "Liquidity Risk", "level2": "Shareholders' Agreements", "level3": "", "level4": ""},
                                 {"question": "What is the exit strategy? Are there any restrictions or committees involved in the process?", "level1": "Liquidity Risk", "level2": "Shareholders' Agreements", "level3": "", "level4": ""}]
ARA_PRIVATE_EQUITY_2= [ {"question": "What is the Fair Market Value (FMV) compared to the Net Invested Capital (NIC), and how does the valuation impact the assessed risk level? Otherwise, refer to the discount percentage between the entry multiple and the reference multiple of comparable companies (or, in cases where other valuation methods are used, the resulting implied multiple) ", "level1": "Liquidity Risk", "level2": "Fair Market Value", "level3": "", "level4": ""},
                            {"question": "What are the estimated remaining holding period and  the target IRR, and how does it affect the investment's risk assessment? ", "level1": "Liquidity Risk", "level2": "Estimated time remaining to reach target IRR", "level3": "", "level4": ""},
                            {"question": "Calculate the Equity Cushion (EC) of the target company using the formula EC = 1 - (Net Financial Position / Enterprise Value), or EC = 1 - (Net Debt / EV); If multiple scenarios or data variations are possible, compute all relevant cases. How does it impact the risk level based on the relationship between capital value and indebtedness?", "level1": "Liquidity Risk", "level2": "Equity Cushion", "level3": "", "level4": ""}]
ARA_PRIVATE_EQUITY_3= [ {"question": "Write the revenues, ebitda, ebitda margin for the last available year. What is the 1-3Y CAGR of company revenue in the last three periods compared to the market?", "level1": "Market risk", "level2": "Comparison of Company and market growth", "level3": "", "level4": ""},
                            {"question": "Write the revenues, ebitda, ebitda margin for the last available year. What is the YoY revenue compared to historical industry distribution?", "level1": "Market risk", "level2": "Comparison of Company and market growth", "level3": "", "level4": ""}, 
                            {"question": "Write the revenues, ebitda, ebitda margin for the last available year. What is the YoY EBITDA margin compared to historical industry distribution?", "level1": "Market risk", "level2": "Comparison of Company and market growth", "level3": "", "level4": ""},
                            {"question": "Find out the structure of the financial lines in the operation and if there is any exposure to interest rate risk: that is unhedged variable rate lines. Find out EBIT and EBITA numbers in the business case (management case) ", "level1": "Market risk", "level2": "Financial stress on the structure of the reference rate curve", "level3": "", "level4": ""}]
ARA_PRIVATE_EQUITY_4= [{"question": "What are the financial covenants associated with the investee's financing agreements? ", "level1": "Operational risk", "level2": "Forward-looking compliance with Covenants", "level3": "", "level4": ""},
                           {"question": "How does the company's performance trend compare to the budget, and what does it indicate about the reliability of the Budget estimates prepared by management? Find out revenue, Ebitda, leverage ratio, last historical value and budget value. ", "level1": "Operational risk", "level2": "Performance trend compared to the budget", "level3": "", "level4": ""},
                             {"question": "What is the Capex/EBITDA ratio for the analyzed period, and how does it impact the risk assessment considering potential integration costs and planned M&A activities? If a specific period is available, please provide the details of both Capex and EBITDA. ", "level1": "Operational risk", "level2": "Other Operational Risks", "level3": "", "level4": ""},
                               {"question": "What are the key accounting and financial reporting practices in place, and how do they impact the risk assessment? If applicable, provide details on the implementation of any mitigating measures such as monthly reporting. ", "level1": "Operational risk", "level2": "Other Operational Risks", "level3": "", "level4": ""}, 
                               {"question": "What is the status of ERP system implementation for management control, and what additional resources are required for software development and integration? If applicable, provide details on planned improvements.", "level1": "Operational risk", "level2": "Other Operational Risks", "level3": "", "level4": ""}, 
                               {"question": "What is the impact of key man presence on the organization's stability and risk assessment? If applicable, provide details on any transition plans or succession strategies in place. ", "level1": "Operational risk", "level2": "Quality of Management and organizational structure", "level3": "", "level4": ""},
                                 {"question": "How does the quality of the management team impact the organization's growth and operational efficiency? If applicable, provide details on planned integrations, key hires, and centralization strategies.", "level1": "Operational risk", "level2": "Quality of Management and organizational structure", "level3": "", "level4": ""},
                                 {"question": "What is the role of a management incentive scheme (MIP) in aligning the interests of top management with company objectives? If available, provide details on approval processes and key stakeholders involved.", "level1": "Operational risk", "level2": "Quality of Management and organizational structure", "level3": "", "level4": ""},
                                 {"question": "What is the governance structure in place for the Board of Directors (BoD), and how does the composition and voting rights impact decision-making and risk assessment? ", "level1": "Operational risk", "level2": "Quality of Management and organizational structure", "level3": "", "level4": ""}, 
                                 {"question": "Are there any negative press hits (involvement in legal/fiscal proceedings) or elements pointing to a reputational risk? ", "level1": "Operational risk", "level2": "Legal or fiscal hits", "level3": "", "level4": ""}]



ARA_PRIVATE_EQUITY_5=[{"question": "What is the gender pay gap for the company, and how does it impact the risk assessment based on the estimated gap and the associated risk level? ", "level1": "ESG Risk", "level2": "ESG - Social", "level3": "", "level4": ""},
                           {"question": "What is the gender diversity ratio within the company, and how does the representation of women in the workforce impact the associated risk level? ", "level1": "ESG Risk", "level2": "ESG - Social", "level3": "", "level4": ""},
                             {"question": "What is the percentage of independent directors on the Board of Directors, and how does the level of independence within the board impact the risk assessment? ", "level1": "ESG Risk", "level2": "ESG - Governance", "level3": "", "level4": ""},
                               {"question": "Is there an incentive plan based on sustainable goals? ", "level1": "ESG Risk", "level2": "ESG - Governance", "level3": "", "level4": ""},
                                 {"question": "What environmental and social certifications does the target company hold?", "level1": "ESG Risk", "level2": "ESG - Governance", "level3": "", "level4": ""}]

ARA_PRIVATE_EQUITY_6= [ {"question": "Business on order?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                           {"question": "Is there sufficient diversification of end markets (at least three)?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                             {"question": "Is there a concentration of suppliers/dependence on strategic suppliers?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                               {"question": "Turnover at top management level?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                               {"question": "Regulatory risk: is the sector in which the company operates subject to restrictive regulations? (e.g., food industry, medical industry etc.)", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""}]

ARA_PRIVATE_EQUITY_7= [ {"question": "Does the nature of the company's business impose any limitations on its expansion that require maintaining geographical proximity?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""}, 
                           {"question": "Does the company operates in a highly competitive environment?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                             {"question": "Does the nature of the business require a careful approach to working capital management?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                               {"question": "Possibility of pass-through of cost increases on sales prices (elasticity of demand and low bargaining power of the end customer)?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                                 {"question": "Does the company operate in a mature industry characterized by low growth market rates (e.g., annual growth rate below 2-3%)?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""},
                                   {"question": "Need to strengthen management/introduce new figures?", "level1": "Specific Risk", "level2": "Specific Risk", "level3": "", "level4": ""}]





ARA_PRIVATE_EQUITY_LIST = [
    ARA_PRIVATE_EQUITY_0,  
    ARA_PRIVATE_EQUITY_1,
    ARA_PRIVATE_EQUITY_2,
    ARA_PRIVATE_EQUITY_3,
    ARA_PRIVATE_EQUITY_4,
    ARA_PRIVATE_EQUITY_5,
    ARA_PRIVATE_EQUITY_6,
    ARA_PRIVATE_EQUITY_7
]





########################################################################################################################################################
########################################################################################################################################################
########################################################################################################################################################
########################################################################################################################################################


########################################################################################################################################################
########################################################################################################################################################
########################################################################################################################################################
########################################################################################################################################################



ITA_ARA_PRIVATE_DEBT_LIST_ITA=  [
    {
      "question": "Qual √® la suddivisione del fatturato della societ√† per aree geografiche? Quanto del fatturato √® generato al di fuori del Paese in cui ha sede la societ√†?",
      "level1": "Rischio Controparte",
      "level2": "Percentuale di fatturato export",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® la dimensione della societ√†, ovvero qual √® il fatturato pi√π recente disponibile?",
      "level1": "Rischio Controparte",
      "level2": "Dimensione dell'emittente",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® la percentuale di fatturato generata dai primi tre clienti e in che modo la concentrazione della clientela impatta sul rischio del business? Fai riferimento anche alla diversificazione dei canali di distribuzione e al modello distributivo adottato (B2B, B2C, ‚Ä¶).",
      "level1": "Rischio Controparte",
      "level2": "Livello concentrazione clientela",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® la percentuale del costo totale di approvvigionamento attribuibile ai primi tre fornitori e in che modo la concentrazione dei fornitori impatta sul rischio del business?",
      "level1": "Rischio Controparte",
      "level2": "Livello concentrazione dei fornitori (supply chain)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Calcola la duration di Macaulay dello strumento con le seguenti caratteristiche: Capitale di EUR 6 milioni, durata di 6 anni, pricing: Euribor a 12 mesi + 8,25% di spread, rimborso del capitale bullet, interessi PIK e commissione upfront del 2,25%.",
      "level1": "Rischio Liquidit√†",
      "level2": "Duration dello strumento finanziario",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Analizza il business plan della societ√† e calcola il coverage ratio atteso per ciascun anno.",
      "level1": "Rischio Liquidit√†",
      "level2": "Coverage ratio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "I flussi di cassa operativi previsti sono sufficienti a coprire interessi e rimborso del debito? Oppure la societ√† dovr√† usare la propria liquidit√† disponibile per pagare?",
      "level1": "Rischio Liquidit√†",
      "level2": "Coverage ratio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Ci sono anni in cui n√© i flussi di cassa n√© la liquidit√† bastano per coprire i debiti?",
      "level1": "Rischio Liquidit√†",
      "level2": "Coverage ratio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Quali sono i covenant finanziari previsti nei contratti di finanziamento?",
      "level1": "Rischio Liquidit√†",
      "level2": "Rispetto Prospettico dei Covenant",
      "level3": "",
      "level4": ""
    },
    {
      "question": "In base al business plan, ci sono anni in cui √® previsto un superamento dei limiti contrattuali previsti per questi covenant (breach)?",
      "level1": "Rischio Liquidit√†",
      "level2": "Rispetto Prospettico dei Covenant",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Calcola l‚Äôheadroom, cio√® il margine tra il valore soglia del covenant e i valori attesi nel piano.",
      "level1": "Rischio Liquidit√†",
      "level2": "Rispetto Prospettico dei Covenant",
      "level3": "",
      "level4": ""
    },
    {
      "question": "In quale anno il margine √® pi√π basso? Quanto √® questo margine minimo?",
      "level1": "Rischio Liquidit√†",
      "level2": "Rispetto Prospettico dei Covenant",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Calcola l‚ÄôEquity Cushion (EC) della societ√† target utilizzando la formula EC = 1 - (Posizione Finanziaria Netta / Enterprise Value), oppure EC = 1 - (Debito Netto / EV). Se sono disponibili pi√π scenari o variazioni nei dati, calcola tutti i casi rilevanti. In che modo ci√≤ impatta sul livello di rischio, in base alla relazione tra valore del capitale e indebitamento?",
      "level1": "Rischio Liquidit√†",
      "level2": "Equity Cushion",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Riporta i ricavi, l‚ÄôEBITDA e l‚ÄôEBITDA margin dell‚Äôultimo anno disponibile. Qual √® il CAGR a 1-3 anni dei ricavi della societ√† negli ultimi tre esercizi, confrontato con quello del mercato? Qual √® il CAGR a 1-3 anni atteso per i prossimi 3 anni rispetto alle proiezioni del business plan della societ√†, confrontato con quello atteso dal mercato per il medesimo arco temporale?",
      "level1": "Rischio di Mercato",
      "level2": "Confronto tra tassi di crescita azienda e mercato",
      "level3": "",
      "level4": ""
    },
    {
      "question": "La societ√† ha ricavi in valuta estera? Se s√¨, quanta parte non √® coperta rispetto al totale del fatturato?",
      "level1": "Rischio di Mercato",
      "level2": "Rischio di Cambio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Le esposizioni non coperte superano il 10%?",
      "level1": "Rischio di Mercato",
      "level2": "Rischio di Cambio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "La societ√† usa strumenti derivati per coprirsi dal rischio cambio?",
      "level1": "Rischio di Mercato",
      "level2": "Rischio di Cambio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® la valuta pi√π volatile rispetto all‚Äôeuro tra quelle in cui √® esposta?",
      "level1": "Rischio di Mercato",
      "level2": "Rischio di Cambio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "A quale settore Damodaran pu√≤ essere associata la Societ√†? Qual √® il levered beta ultimo registrato per questo settore secondo i dati di damodaran - area di riferimento Europa Occidentale?",
      "level1": "Rischio di Mercato",
      "level2": "Average levered beta settoriale nel periodo di riferimento",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® il divario retributivo di genere all'interno della societ√† e in che modo questo incide sulla valutazione del rischio, considerando l'entit√† stimata del gap e il livello di rischio associato?",
      "level1": "Rischio ESG",
      "level2": "ESG - Social",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® il tasso di diversit√† di genere all'interno dell‚Äôazienda e in che modo la rappresentanza femminile nella forza lavoro incide sul livello di rischio associato?",
      "level1": "Rischio ESG",
      "level2": "ESG - Social",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® la percentuale di amministratori indipendenti nel Consiglio di Amministrazione e in che modo il livello di indipendenza del board incide sulla valutazione del rischio?",
      "level1": "Rischio ESG",
      "level2": "ESG - Governance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Esiste un piano di incentivazione basato su obiettivi di sostenibilit√†?",
      "level1": "Rischio ESG",
      "level2": "ESG - Governance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Quali certificazioni ambientali e sociali possiede la societ√† target?",
      "level1": "Rischio ESG",
      "level2": "ESG - Governance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Analizza lo strumento di debito descritto: qual √® il suo livello di seniority (es. Senior, Mezzanine, Junior)? Sono previste garanzie a supporto dello strumento? Se s√¨, quali sono e che natura hanno (es. pegni, ipoteche, garanzie personali o corporate)?",
      "level1": "Emissione: Subordinazione e Garanzie",
      "level2": "Livello di seniority dello strumento finanziario",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Che tipo di operazione √® descritta nel documento? Si tratta, ad esempio, di un'operazione di LBO, Direct Lending, Acquisition Financing o altro?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Contratto di finanziamento (complessit√† operazione/documentazione)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Quali sono le parti coinvolte nella transazione (es. sponsor, societ√† target, banche, fondi)?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Contratto di finanziamento (complessit√† operazione/documentazione)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® il ruolo del fondo nella transazione? Agisce come finanziatore diretto, coinvestitore, oppure sottoscrive strumenti subordinati?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Contratto di finanziamento (complessit√† operazione/documentazione)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Il finanziamento √® sindacato o bilaterale? Sono indicate la qualit√† e la tipologia degli altri partecipanti all‚Äôoperazione (es. istituzioni finanziarie, fondi di debito, banche commerciali)?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Contratto di finanziamento (complessit√† operazione/documentazione)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "La documentazione contrattuale presenta elementi di complessit√† rilevanti (es. clausole restrittive, condizioni sospensive, covenant particolarmente stringenti)? Sono previste o attese modifiche in senso restrittivo del quadro contrattuale?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Contratto di finanziamento (complessit√† operazione/documentazione)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Il documento fornisce indicazioni sulla presenza di obblighi informativi verso il FIA? Se s√¨, quali sono e con quale frequenza devono essere rispettati (es. mensile, trimestrale, annuale)?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Efficacia e rispetto degli obblighi informativi verso il FIA",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Il documento riporta la presenza di covenant finanziari? Se s√¨, quali sono (es. Leverage Ratio, DSCR?)",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Parametri finanziari",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® la frequenza con cui vengono rilevati i covenant finanziari (es. trimestrale, semestrale)? Viene indicato un livello di headroom rispetto ai limiti imposti?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Parametri finanziari",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Sono contrattualmente previsti meccanismi di covenant holiday o equity cure?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Parametri finanziari",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Qual √® la struttura del tasso di interesse dello strumento di debito descritto? Si tratta di cedole fisse, variabili (es. Euribor + spread fisso), con meccanismi di ratchet up/down o equity kicker?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Tipologia remunerazione",
      "level3": "",
      "level4": ""
    },
    {
      "question": "La remunerazione pu√≤ essere modificata nel tempo? Sono previste clausole che comportano variazioni automatiche della cedola (es. ratchet up/down)? Se s√¨, di che tipo?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Tipologia remunerazione",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Sono presenti meccanismi opzionali come equity kicker? Se s√¨, √® indicato se l‚Äôopzione call sull‚Äôequity kicker risulta ‚Äúin the money‚Äù alla data di analisi?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Tipologia remunerazione",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Il contratto prevede clausole di rimborso anticipato o opzioni di richiamo da parte dell‚Äôemittente? Se s√¨, in quali condizioni possono essere attivate? Esistono delle penalties in caso di rimborso anticipato volontario?",
      "level1": "Emissione: Rischi integrativi",
      "level2": "Clausole di rimborso anticipato",
      "level3": "",
      "level4": ""
    }
  ]




ARA_PRIVATE_DEBT_1= [
    {
      "question": "What is the breakdown of the company's revenue by geographical area? How much of the revenue is generated outside the company's home country?",
      "level1": "Counterparty Risk",
      "level2": "Percentage of export revenue",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What is the size of the company, i.e., what is the most recent available revenue?",
      "level1": "Counterparty Risk",
      "level2": "Issuer size",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What percentage of revenue is generated by the top three clients, and how does customer concentration impact business risk? Also, refer to the diversification of distribution channels and the distribution model adopted (B2B, B2C, etc.).",
      "level1": "Counterparty Risk",
      "level2": "Customer concentration level",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What percentage of the total procurement cost is attributable to the top three suppliers, and how does supplier concentration impact business risk?",
      "level1": "Counterparty Risk",
      "level2": "Supplier concentration level (supply chain)",
      "level3": "",
      "level4": ""
    }]
ARA_PRIVATE_DEBT_2=[
    {
      "question": "Calculate the Macaulay duration of the instrument with the following characteristics: Capital of EUR 6 million, duration of 6 years, pricing: 12-month Euribor + 8.25% spread, bullet capital repayment, PIK interest, and an upfront fee of 2.25%.",
      "level1": "Liquidity Risk",
      "level2": "Financial instrument duration",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Analyze the company's business plan and calculate the expected coverage ratio for each year.",
      "level1": "Liquidity Risk",
      "level2": "Coverage ratio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Are the projected operating cash flows sufficient to cover interest and debt repayment? Or will the company have to use its available liquidity to pay?",
      "level1": "Liquidity Risk",
      "level2": "Coverage ratio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Are there any years where neither cash flows nor liquidity are sufficient to cover debts?",
      "level1": "Liquidity Risk",
      "level2": "Coverage ratio",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What are the financial covenants stipulated in the financing agreements?",
      "level1": "Liquidity Risk",
      "level2": "Prospective Covenant Compliance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Based on the business plan, are there any years in which an v∆∞·ª£t qu√° the contractual limits for these covenants (breach) is expected?",
      "level1": "Liquidity Risk",
      "level2": "Prospective Covenant Compliance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Calculate the headroom, i.e., the margin between the covenant threshold and the expected values in the plan.",
      "level1": "Liquidity Risk",
      "level2": "Prospective Covenant Compliance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "In which year is the margin lowest? How much is this minimum margin?",
      "level1": "Liquidity Risk",
      "level2": "Prospective Covenant Compliance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Calculate the Equity Cushion (EC) of the target company using the formula EC = 1 - (Net Financial Position / Enterprise Value), or EC = 1 - (Net Debt / EV). If multiple scenarios or data variations are available, calculate all relevant cases. How does this impact the risk level, based on the relationship between equity value and indebtedness?",
      "level1": "Liquidity Risk",
      "level2": "Equity Cushion",
      "level3": "",
      "level4": ""
    }]
ARA_PRIVATE_DEBT_3= [ {
      "question": "Report the revenue, EBITDA, and EBITDA margin for the latest available year. What is the 1-3 year CAGR of the company's revenue over the last three fiscal years, compared to that of the market? What is the expected 1-3 year CAGR for the next 3 years according to the company's business plan projections, compared to the market's expected CAGR for the same period?",
      "level1": "Market Risk",
      "level2": "Comparison of company and market growth rates",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Does the company have foreign currency revenues? If so, how much of it is not hedged compared to total revenue?",
      "level1": "Market Risk",
      "level2": "Exchange Rate Risk",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Do unhedged exposures exceed 10%?",
      "level1": "Market Risk",
      "level2": "Exchange Rate Risk",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Does the company use derivative instruments to hedge against exchange rate risk?",
      "level1": "Market Risk",
      "level2": "Exchange Rate Risk",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Which currency is most volatile relative to the Euro among those the company is exposed to?",
      "level1": "Market Risk",
      "level2": "Exchange Rate Risk",
      "level3": "",
      "level4": ""
    },
    {
      "question": "To which Damodaran sector can the Company be associated? What is the latest levered beta recorded for this sector according to Damodaran data - Western Europe reference area?",
      "level1": "Market Risk",
      "level2": "Average levered beta for the sector in the reference period",
      "level3": "",
      "level4": ""
    }]
ARA_PRIVATE_DEBT_4=[
    {
      "question": "What is the gender pay gap within the company, and how does this affect the risk assessment, considering the estimated size of the gap and the associated risk level?",
      "level1": "ESG Risk",
      "level2": "ESG - Social",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What is the gender diversity rate within the company, and how does female representation in the workforce affect the associated risk level?",
      "level1": "ESG Risk",
      "level2": "ESG - Social",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What is the percentage of independent directors on the Board of Directors, and how does the board's independence level affect the risk assessment?",
      "level1": "ESG Risk",
      "level2": "ESG - Governance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Is there an incentive plan based on sustainability objectives?",
      "level1": "ESG Risk",
      "level2": "ESG - Governance",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What environmental and social certifications does the target company possess?",
      "level1": "ESG Risk",
      "level2": "ESG - Governance",
      "level3": "",
      "level4": ""
    }]
ARA_PRIVATE_DEBT_5=[
    {
      "question": "Analyze the described debt instrument: what is its seniority level (e.g., Senior, Mezzanine, Junior)? Are there any guarantees supporting the instrument? If so, what are they and what is their nature (e.g., pledges, mortgages, personal or corporate guarantees)?",
      "level1": "Issuance: Subordination and Guarantees",
      "level2": "Seniority level of the financial instrument",
      "level3": "",
      "level4": ""
    }]
ARA_PRIVATE_DEBT_6= [
    {
      "question": "What type of operation is described in the document? Is it, for example, an LBO, Direct Lending, Acquisition Financing, or something else?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financing agreement (complexity of operation/documentation)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What are the parties involved in the transaction (e.g., sponsor, target company, banks, funds)?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financing agreement (complexity of operation/documentation)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What is the fund's role in the transaction? Does it act as a direct lender, co-investor, or subscribe to subordinated instruments?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financing agreement (complexity of operation/documentation)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Is the financing syndicated or bilateral? Are the quality and type of other participants in the operation indicated (e.g., financial institutions, debt funds, commercial banks)?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financing agreement (complexity of operation/documentation)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Does the contractual documentation present significant complexity elements (e.g., restrictive clauses, conditions precedent, particularly stringent covenants)? Are restrictive changes to the contractual framework foreseen or expected?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financing agreement (complexity of operation/documentation)",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Does the document provide indications on the presence of informational obligations towards the FIA? If so, what are they and how often must they be complied with (e.g., monthly, quarterly, annually)?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Effectiveness and compliance with informational obligations towards the FIA",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Does the document report the presence of financial covenants? If so, what are they (e.g., Leverage Ratio, DSCR?)",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financial parameters",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What is the frequency with which financial covenants are measured (e.g., quarterly, semi-annually)? Is a level of headroom indicated relative to the imposed limits?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financial parameters",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Are covenant holiday or equity cure mechanisms contractually provided?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Financial parameters",
      "level3": "",
      "level4": ""
    },
    {
      "question": "What is the interest rate structure of the described debt instrument? Does it involve fixed coupons, variable coupons (e.g., Euribor + fixed spread), with ratchet up/down mechanisms, or an equity kicker?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Remuneration type",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Can the remuneration be modified over time? Are there clauses that lead to automatic changes in the coupon (e.g., ratchet up/down)? If so, what type?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Remuneration type",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Are optional mechanisms such as equity kickers present? If so, is it indicated whether the call option on the equity kicker is ‚Äúin the money‚Äù as of the analysis date?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Remuneration type",
      "level3": "",
      "level4": ""
    },
    {
      "question": "Does the contract provide for early repayment clauses or call options by the issuer? If so, under what conditions can they be activated? Are there penalties for voluntary early repayment?",
      "level1": "Issuance: Integrative Risks",
      "level2": "Early repayment clauses",
      "level3": "",
      "level4": ""
    }
  ]
ARA_PRIVATE_DEBT_LIST= [ARA_PRIVATE_DEBT_1,ARA_PRIVATE_DEBT_2,ARA_PRIVATE_DEBT_3,ARA_PRIVATE_DEBT_4,ARA_PRIVATE_DEBT_5,ARA_PRIVATE_DEBT_6]
NUMBER_API_CALL_PRIVATE_DEBT = 6



ARA_SMART_VENTURE_CAPITAL_1 = [  
    {  
        "question": "Who are the company's founders? Do they have previous entrepreneurial experience? If so, what entrepreneurial experience do they have? Have they had any successful exits?",  
        "level1": "Counterparty Risk",  
        "level2": "Previous entrepreneurial experiences",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Describe the academic and professional background of the founders",  
        "level1": "Counterparty Risk",  
        "level2": "Previous entrepreneurial experiences",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Are all the founders actively involved in the operations of the Company?",  
        "level1": "Counterparty Risk",  
        "level2": "Previous entrepreneurial experiences",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Are the founders engaged in any other activities in parallel? If so, what is their level of commitment to the Company?",  
        "level1": "Counterparty Risk",  
        "level2": "Previous entrepreneurial experiences",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Share of capital held by founders after the investment round",  
        "level1": "Counterparty Risk",  
        "level2": "Founders‚Äô shareholding",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Share of stock options assigned to the founders post-round",  
        "level1": "Counterparty Risk",  
        "level2": "Founders‚Äô shareholding",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Are there any SFPs or SAFEs that, upon conversion, could dilute the founders' equity stake?",  
        "level1": "Counterparty Risk",  
        "level2": "Founders‚Äô shareholding",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Are there financial covenants associated with the investee's financing agreements? If so, what are the financial metrics to which the covenants are linked?",  
        "level1": "Counterparty Risk",  
        "level2": "Forward-looking compliance with Covenants",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Have any actual or potential breaches of the aforementioned covenants been detected or foreseen?",  
        "level1": "Counterparty Risk",  
        "level2": "Forward-looking compliance with Covenants",  
        "level3": "",  
        "level4": ""  
    }  
]  


ARA_SMART_VENTURE_CAPITAL_2 = [  
    {  
        "question": "How does the company's performance trend compare to the budget?",  
        "level1": "Liquidity Risk",  
        "level2": "Milestones achievement and review of BP",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Has the new business plan/budget been revised compared to the previous one? What has changed?",  
        "level1": "Liquidity Risk",  
        "level2": "Milestones achievement and review of BP",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Compare actual revenues, ebitda and KPIs vs budget, and provide the variations in these metrics compared to the previous year.",  
        "level1": "Liquidity Risk",  
        "level2": "Milestones achievement and review of BP",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What are the reasons for any delays in actual performance compared to forecasts?",  
        "level1": "Liquidity Risk",  
        "level2": "Milestones achievement and review of BP",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "According to the business plan, when is expected to reach the break-even point? i.e. to achieve positive EBITDA? What is the EBITDA at year-end?",  
        "level1": "Liquidity Risk",  
        "level2": "Operational Break Even Point (EBITDA)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Post-investment round, what is the company's runway?",  
        "level1": "Liquidity Risk",  
        "level2": "Cash Runway",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Does the Company plan to raise additional capital in the future in the form of equity or debt?",  
        "level1": "Liquidity Risk",  
        "level2": "Cash Runway",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Is the Company's business capital intensive?",  
        "level1": "Liquidity Risk",  
        "level2": "Cash Runway",  
        "level3": "",  
        "level4": ""  
    },  
]  


ARA_SMART_VENTURE_CAPITAL_3 = [  
    {  
        "question": "company‚Äôs actual revenues",  
        "level1": "Specific Risk",  
        "level2": "Momentum",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "If the company is pre-revenue, provide the product development TRL (Technology Readiness Level) if specified in the memo.",  
        "level1": "Specific Risk",  
        "level2": "Momentum",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "If the company is pre-revenue and operates in the biotech/medtech sector, identify whether the company is in the clinical or preclinical phase, and indicate when the clinical phase is expected to begin and when regulatory approval is expected.",  
        "level1": "Specific Risk",  
        "level2": "Momentum",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "How scalable is the business model?",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (digital and/or life science companies that are, or are about to, generating revenues)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What stage of development is the technology/product/service? Give me an answer based on these thresholds:\n - final version complete and validated on the market; \n - final version complete and validated on the market, but some physiological improvements to the technology/product/service are needed;\n - Developed, but new relevant features have to be implemented/improved;\n - technology/product/service to be finalised prior to market validation/necessary post-testing changes;\n - Development phase/uncertain.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (digital and/or life science companies that are, or are about to, generating revenues)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Indicate if there are any relevant strategic development partnerships.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (digital and/or life science companies that are, or are about to, generating revenues)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What is the business model? Give me an answer based on these thresholds:\n - recurring B2B/recurring B2B2C;\n - recurring B2C;\n - non-recurring B2B/non-recurring B2B2C;\n - non-recurring B2C; \n - not yet defined.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (digital and/or life science companies that are, or are about to, generating revenues)",  
        "level3": "",  
        "level4": ""  
    },
    {  
        "question": "Indicate if there are any relevant commercial partnerships.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (digital and/or life science companies that are, or are about to, generating revenues)",  
        "level3": "",  
        "level4": ""  
    },   
    {  
        "question": "What is the total amount of costs required to reach the BeP? Sum all the costs expected over the years until the year in which a positive EBITDA is expected.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (digital and/or life science companies that are, or are about to, generating revenues)",  
        "level3": "",  
        "level4": ""  
    },  
        {  
        "question": "What is the company‚Äôs expected approval regulatory pattern? Give me an answer based on these thresholds: \n - Generic drug development or CE Mark level 3; \n - Biosimilar 501b and similar development or FDA 510K; \n - Fast track and orphan drug or CE Mark level 2; \n - Classic development (FDA or EMA) / FDA de novo e/o CE Mark level 1; Classic development (both FDA and EMA) / FDA PMA.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (life science companies that need to achieve regulatory approval)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What stage of development is the technology/product/service? Give me an answer based on these thresholds: \n - Product approved and ready for commercialisation or already commercialised; \n - Pre-clinical development completed, clinical trials in progress / Development completed, trials to be completed;\n - Early discovery from Hit to Lead until completion pre-clinical development / completed, until design freeze; \n - Early discovery until Hit to Lead / Embryonal development phase;\n - Negative outcome of clinical and/or pre-clinical trial or lack of data.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (life science companies that need to achieve regulatory approval)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What is the expected distribution model? \n - dedicated reimbursement code available/pre-existing reimbursement code available;\n - expected, potentially obtainable reimbursement code but not yet available;\n - out-of-pocket with identified distribution Partner;\n - out-of-pocket with distribution partner to be identified;\n - distribution model not defined.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (life science companies that need to achieve regulatory approval)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What is the total amount of costs required to reach the regulatory approval? Sum all the costs expected over the years until the year in which the regulatory approval is expected.",  
        "level1": "Specific Risk",  
        "level2": "Business Risk (life science companies that need to achieve regulatory approval)",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "How will the funds from this round be allocated (use of funds) across the main operational and development areas?",  
        "level1": "Specific Risk",  
        "level2": "execution",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What are the key objective to be achieved with the funds raised, and what is the expected timeline? What are the main technical or operational complexities that could delay or hinder execution of the plan?",  
        "level1": "Specific Risk",  
        "level2": "execution",  
        "level3": "",  
        "level4": ""  
    }  
]  

ARA_SMART_VENTURE_CAPITAL_4 = [  
    {  
        "question": "What is the market/industry growth rate?",  
        "level1": "Market risk",  
        "level2": "Market/industry growth",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What is the competition level of the market/industry in which the company operates? What types of competitors are present in the market, and how intense is the threat posed by each of them (e.g., other startups, SMEs with scalable models, large companies with replacement products, large corporations with strong R&D and marketing, many large players and high competition/no competitors)?",  
        "level1": "Market risk",  
        "level2": "Market/industry growth",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Is the market concentrated (a few major players) or fragmented (many small players)? Are there entry barriers that limit competition or make market entry easier?",  
        "level1": "Market risk",  
        "level2": "Market/industry growth",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Is the industry characterized by competition based on price, innovation, service, or other factors?",  
        "level1": "Market risk",  
        "level2": "Market/industry growth",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What is the main competitive advantage of our offering (price, quality, innovation, brand, service, etc.)?",  
        "level1": "Market risk",  
        "level2": "Market/industry growth",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What are the main threats (e.g., new entrants, substitute products, regulatory changes)? Are there trends or technological changes that are reshaping the competitive landscape?",  
        "level1": "Market risk",  
        "level2": "Market/industry growth",  
        "level3": "",  
        "level4": ""  
    }  
]  

ARA_SMART_VENTURE_CAPITAL_5 = [  
    # KRI: Nature of co-investors  
    {  
        "question": "Who are the co-investors? Does the current cap-table include venture capital players (investment funds and business angels) and strategic investors?",  
        "level1": "Operational risk",  
        "level2": "Nature of co-investors",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Does the round under consideration consist of an aucap (equity) or the subscription of a convertible loan / SFP / SAFE instrument? In the case of aucap what type of round is it? What is the amount of the round? How much does the Fund invest? What is the Pre-money Valuation of the Company? What share of the share capital will the Fund hold post-round? Does the round provide for the payment of amounts in several tranches? Are subsequent tranches subject to the achievement of certain milestones? If so, what kind of milestones are they?",  
        "level1": "Operational risk",  
        "level2": "Other Operational Risks",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Post round how many board seats does the Fund have? How many members will the Board of Directors consist of? Is the Fund the lead investor in the round?",  
        "level1": "Operational risk",  
        "level2": "Other Operational Risks",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Has turnover occurred within the Company? Which people were involved? Has a cost-cutting policy been implemented with staff cuts over the last 12 months?",  
        "level1": "Operational risk",  
        "level2": "Other Operational Risks",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "How many shareholders are there in the cap-table before the round and how many will there be after the round? In the case of cap-tables with more than 15 shareholders, is the share capital highly fragmented or are most of the shares held by only a few?",  
        "level1": "Operational risk",  
        "level2": "Other Operational Risks",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Has an Advisory Board been formally established? Alternatively, are external advisors there?",  
        "level1": "Operational risk",  
        "level2": "Other Operational Risks",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Will the Fund have Liquidation preference? What kind?",  
        "level1": "Operational risk",  
        "level2": "Exit protection clauses",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Will the Fund have Tag along clause?",  
        "level1": "Operational risk",  
        "level2": "Exit protection clauses",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Will the Fund have Drag along clause?",  
        "level1": "Operational risk",  
        "level2": "Exit protection clauses",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Will the Fund have anti dilution clause? What kind of mechanism?",  
        "level1": "Operational risk",  
        "level2": "Exit protection clauses",  
        "level3": "",  
        "level4": ""  
    },
    {  
        "question": "Will the Fund have the mandate to sell? ",  
        "level1": "Operational risk",  
        "level2": "Exit protection clauses",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What is the exit strategy? ",  
        "level1": "Operational risk",  
        "level2": "Exit protection clauses",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Are there any legal, reputational and/or fiscal risks associated with the investment in the Company under analysis?",  
        "level1": "Operational risk",  
        "level2": "Legal, reputational and/or fiscal risks",  
        "level3": "",  
        "level4": ""  
    }
]  

ARA_SMART_VENTURE_CAPITAL_6 = [    
    {  
        "question": "What is the gender pay gap for the company, and how does it impact the risk assessment based on the estimated gap and the associated risk level?",  
        "level1": "ESG Risk",  
        "level2": "ESG - Social",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What is the gender diversity ratio within the company, and how does the representation of women in the workforce impact the associated risk level?",  
        "level1": "ESG Risk",  
        "level2": "ESG - Social",  
        "level3": "",  
        "level4": ""  
    },   
    {  
        "question": "What is the percentage of independent directors on the Board of Directors, and how does the level of independence within the board impact the risk assessment?",  
        "level1": "ESG Risk",  
        "level2": "ESG - Governance",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Is there an incentive plan based on sustainable goals?",  
        "level1": "ESG Risk",  
        "level2": "ESG - Governance",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What environmental and social certifications does the target company hold?",  
        "level1": "ESG Risk",  
        "level2": "ESG - Governance",  
        "level3": "",  
        "level4": ""  
    }  
]  


ARA_SMART_VENTURE_CAPITAL_7 = [  
    {  
        "question": "How many years ago was the company founded?",  
        "level1": "Specific Risk",  
        "level2": "Specific Risk",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What investment round is it? Give me an answer based on these thresholds:\n - Seed \n - Serie A \n - Serie B \n - Series C or further",  
        "level1": "Specific Risk",  
        "level2": "Specific Risk",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "Company‚Äôs actual revenues, size in terms of staff and countries in which it currently operates",  
        "level1": "Specific Risk",  
        "level2": "Specific Risk",  
        "level3": "",  
        "level4": ""  
    },  
    {  
        "question": "What stage of development is the technology/product/service? Give me an answer based on these thresholds:\n - Early Drug Discovery;\n - Pre-clinical;\n - Clinical;\n - Certification achieved;\n - Commercialization",  
        "level1": "Specific Risk",  
        "level2": "Specific Risk",  
        "level3": "",  
        "level4": ""  
    }  
]  